(Q68325308)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1683492%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Clinical signs and laboratory markers in predicting progression to AIDS in HIV-1 infected patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1683492%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Clinical signs and laboratory markers in predicting progression to AIDS in HIV–1 infected patients (English)

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

28 October 2022

author name string

L. Morfeldt-Månson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1683492

28 October 2022

B. Böttiger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1683492

28 October 2022

B. Nilsson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1683492

28 October 2022

L. V. von Stedingk

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1683492

28 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1683492

28 October 2022

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1683492%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 September 2019

http://www.tandfonline.com/doi/pdf/10.3109/00365549109075092

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

28 October 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1683492%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1683492%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1683492%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

443-449

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1683492%20AND%20SRC:MED&resulttype=core&format=json

A six-year follow-up of HIV-infected homosexual men with lymphadenopathy. Evidence for an increased risk for developing AIDS after the third year of lymphadenopathy

23 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

Predicting who will progress to AIDS.

28 October 2022

2

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

AIDS two months after primary human immunodeficiency virus infection

28 October 2022

3

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men

28 October 2022

4

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus

28 October 2022

5

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

Predictive markers of AIDS: a follow-up of lymphocyte subsets and HIV serology in a cohort of patients with lymphadenopathy

28 October 2022

6

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men.

28 October 2022

8

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection.

28 October 2022

9

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

Elevated serum beta-2-microglobulin--a prognostic marker for development of AIDS among patients with persistent generalized lymphadenopathy

28 October 2022

11

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort

28 October 2022

12

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome

28 October 2022

13

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and the risk of developing AIDS.

28 October 2022

14

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

Dermatitis of the face, yellow toe nail changes, hairy leukoplakia and oral candidiasis are clinical indicators of progression to AIDS/opportunistic infection in patients with HIV infection

28 October 2022

15

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

Radioimmunoprecipitation and Western blotting with sera of human immunodeficiency virus infected patients: a comparative study

28 October 2022

19

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

HIV-serology and lymphocyte subsets in relation to therapy and clinical development in haemophiliacs.

28 October 2022

20

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

Characterization of T lymphocyte responses during primary infection with human immunodeficiency virus

28 October 2022

23

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

Serum cholesterol and the risk of colorectal cancer

28 October 2022

24

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

From persistent generalised lymphadenopathy to AIDS: who will progress?

28 October 2022

25

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

Serological response in patients with chronic asymptomatic human immunodeficiency virus infection

28 October 2022

26

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

Quantitation of β2-Microglobulin and Other Immune Characteristics in a Prospective Study of Men at Risk for Acquired Immune Deficiency Syndrome

28 October 2022

28

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

Neopterin and beta 2-microglobulin as markers for AIDS

28 October 2022

30

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

Secretory IgA antibodies to human immunodeficiency virus in the parotid saliva of patients with AIDS and AIDS-related complex

28 October 2022

31

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

A model-based estimate of the mean incubation period for AIDS in homosexual men

28 October 2022

32

1 reference

https://api.crossref.org/works/10.3109/00365549109075092

28 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1683492%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference